{"id":79130,"date":"2014-12-16T19:53:08","date_gmt":"2014-12-17T00:53:08","guid":{"rendered":"http:\/\/www.eugenesis.com\/national-academy-of-inventors-names-two-sanford-burnham-researchers-as-charter-fellows\/"},"modified":"2014-12-16T19:53:08","modified_gmt":"2014-12-17T00:53:08","slug":"national-academy-of-inventors-names-two-sanford-burnham-researchers-as-charter-fellows","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/nanomedicine-2\/national-academy-of-inventors-names-two-sanford-burnham-researchers-as-charter-fellows.php","title":{"rendered":"National Academy of Inventors Names Two Sanford-Burnham Researchers as Charter Fellows"},"content":{"rendered":"<p><p>Contact Information         <\/p>\n<p>      Available for logged-in reporters only    <\/p>\n<p>    Newswise  La Jolla, Calif., December 16, 2014  Two    professors at Sanford-Burnham Medical Research Institute    (Sanford-Burnham) have been named Charter Fellows of the    National Academy of Inventors (NAI): Erkki Ruoslahti, M.D.,    Ph.D., distinguished professor and former president of    Sanford-Burnham, and Kristiina Vuori, M.D., Ph.D., current    president of the Institute. Ruoslahti and Vuori are now part of    a group of 414 NAI Fellows from more than 150 prestigious    research universities, government, and nonprofit research    institutions.  <\/p>\n<p>    Election to the NAI Fellows is a significant professional    distinction accorded to academic inventors who have    demonstrated a highly prolific spirit of innovation in creating    or facilitating outstanding inventions that have made a    tangible impact on quality of life, economic development, and    the welfare of society.  <\/p>\n<p>    Im honored to be named a Charter Fellow of the NAI, said    Vuori. I owe a large part of this distinction to the talented    scientists, staff, and students I have worked with at    Sanford-Burnham over the years.  <\/p>\n<p>    Academic inventors are elected by their peers for innovative    contributions in areas such as patenting and licensing,    innovative discovery and technology, significant impact on    society, and support and enhancement of innovation.  <\/p>\n<p>    An internationally recognized leader in nanomedicine, Ruoslahti    focuses his research on directing drugs to sites of disease.    His main discovery and invention is the integrin-binding    tripeptide motif RGD, a sequence within fibronectin that    mediates cell attachment, and is found in numerous other    cell-attachment proteins. His recent work has contributed to    better tumor imaging and improving drug delivery to specific    disease sites.  <\/p>\n<p>    It is a great honor to be named a Fellow of the NAI, said    Ruoslahti. There are so many giants of innovation that have    received this distinction, and Im grateful to be part of that    group.  <\/p>\n<p>    Ruoslahti holds 314 issued patents, and is the founder of the    Center for Nanomedicine at UC Santa Barbara, a member of the    U.S. National Academy of Sciences and the Institute for    Medicine, and a member of the Academy of Arts and Sciences. He    is the recipient of the Japan Prize, Gairdner Award, Clowes    Award, Pasarow Award, and Jacobaeus Prize, and is a 2012    Thomson Reuters Citation Laureate. He is Knight and Commander    of the Orders of the White Rose of Finland and the Lion of    Finland.  <\/p>\n<p>    Vuori joined the faculty of Sanford-Burnham in 1996 and has    been president of Sanford-Burnham since 2010. She is also    professor and holder of the Pauline and Stanley Presidential    Chair, and served as director of Sanford-Burnhams    NCI-designated Cancer Center from 2005 until 2013. Her main    research focus is aimed at unraveling the molecular mechanisms    of cancer metastasis, particularly the process that makes    normal cells adhesion dependent. Normal cells adhere to their    microenvironment for survival; if they become detached they    will die. Cancer cells are somehow able to detach from their    surroundings and move to other tissues in the body and survive    and grow. Understanding the mechanisms of cell adhesion opens    new approaches to preventing cancer metastasis.  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>See more here:<br \/>\n<a target=\"_blank\" href=\"http:\/\/www.newswise.com\/articles\/view\/627504\/?sc=rsmn\/RK=0\/RS=votUQ5K8DcLj2lUWntuE1BbDKsY-\" title=\"National Academy of Inventors Names Two Sanford-Burnham Researchers as Charter Fellows\">National Academy of Inventors Names Two Sanford-Burnham Researchers as Charter Fellows<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Contact Information Available for logged-in reporters only Newswise La Jolla, Calif., December 16, 2014 Two professors at Sanford-Burnham Medical Research Institute (Sanford-Burnham) have been named Charter Fellows of the National Academy of Inventors (NAI): Erkki Ruoslahti, M.D., Ph.D., distinguished professor and former president of Sanford-Burnham, and Kristiina Vuori, M.D., Ph.D., current president of the Institute. Ruoslahti and Vuori are now part of a group of 414 NAI Fellows from more than 150 prestigious research universities, government, and nonprofit research institutions <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/nanomedicine-2\/national-academy-of-inventors-names-two-sanford-burnham-researchers-as-charter-fellows.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[577779],"tags":[],"class_list":["post-79130","post","type-post","status-publish","format-standard","hentry","category-nanomedicine-2"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/79130"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=79130"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/79130\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=79130"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=79130"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=79130"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}